STAT+: Pharmalittle: FDA plans rapid review of Omicron vaccines and drugs; Califf would keep Woodcock at FDA
The FDA is laying the groundwork for the rapid review of Omicron-targeted vaccines and drugs if they turn out to be needed.
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured
